Scientific Sessions 2024  /  Featured Science: Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations  /  Discussant: SCAN-MP
Logo

American Heart Association

  18
  0

Final ID:

Discussant: SCAN-MP

  • Alexander, Kevin  ( Stanford University , Palo Alto , California , United States )
    • Author Disclosures:
    Kevin Alexander: DO have relevant financial relationships ; Consultant:Arbor Biotechnologies:Active (exists now) ; Consultant:Bristol Myers Squibb:Past (completed) ; Consultant:Prothena:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Intellia:Past (completed) ; Consultant:Alnylam:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations

Monday, 11/18/2024 , 09:45AM - 11:00AM

Featured Science

More abstracts on this topic:
Discussant: OLE & HELIOS-B

Grogan Martha, Kittleson Michelle, Nair Ajith, Grodin Justin, Ambardekar Amrut

The prevalence of transthyretin cardiac amyloidosis in older Black and Hispanic individuals with heart failure: The Screening for Cardiac Amyloidosis with Nuclear imaging in Minority Populations Study

Ruberg Frederick, Blaner William, Deluca Albert, Johnson Lynne, Kinkhabwala Mona, Leb Jay, Mintz Akiva, Lavalley Michael, Einstein Andrew, Cohn Elizabeth, Kelly Jeffery, Teruya Sergio, Miller Edward, Maurer Mathew, Helmke Stephen, Fine Denise, Kurian Damian, Raiszadeh Farbod, Connors Lawreen, Prokaeva Tatiana, Pandey Shivda

More abstracts from these authors:
CRISPR Quagmire: Weighing the Risks of Gene Therapies

Mammen Pradeep, Alexander Kevin

Disparities in the Management and Outcomes of Cardiac Amyloidosis in Underrepresented Populations. -how can we bridge the gaps? 10 minutes

Bullock-palmer Renee, Alexander Kevin

You have to be authorized to contact abstract author. Please, Login
Not Available